- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 281078, 6 pages
Screening of -Glucosidase Inhibitory Activity from Some Plants of Apocynaceae, Clusiaceae, Euphorbiaceae, and Rubiaceae
Department of Pharmacy, Faculty of Mathematics and Sciences, University of Indonesia, Depok 16424, Indonesia
Received 30 July 2011; Revised 8 September 2011; Accepted 9 September 2011
Academic Editor: Munekazu Iinuma
Copyright © 2012 Berna Elya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Diabetes mellitus (DM) is recognized as a serious global health problem that is characterized by high blood sugar levels. Type 2 DM is more common in diabetic populations. In this type of DM, inhibition of -glucosidase is a useful treatment to delay the absorption of glucose after meals. As a megabiodiversity country, Indonesia still has a lot of potential unexploited forests to be developed as a medicine source, including as the -glucosidase inhibitor. In this study, we determine the -glucosidase inhibitory activity of 80% ethanol extracts of leaves and twigs of some plants from the Apocynaceae, Clusiaceae, Euphorbiaceae, and Rubiaceae. Inhibitory activity test of the -glucosidase was performed in vitro using spectrophotometric methods. Compared with the control acarbose (IC50 117.20 μg/mL), thirty-seven samples of forty-five were shown to be more potent -glucosidase inhibitors with IC50 values in the range 2.33–112.02 μg/mL.
Diabetes mellitus (DM) is the most common endocrine disease worldwide. About 173 million people suffer from diabetes mellitus. The number of people with diabetes mellitus will more than double over the next 25 years to reach a total of 366 million by 2030 . In 2000, Indonesia is ranked the fourth largest number of people with DM, after India, China, and the United States, which is about 8.4 million people. The amount is expected to rise to 21.3 million in 2030 .
DM consists of several types, one of which is noninsulin-dependent diabetes mellitus (type 2 DM). This type of DM is more common, reaching 90–95% of the population with DM . This increasing trend in type 2 DM has become a serious medical concern worldwide that prompts every effort in exploring for new therapeutic agents to stem its progress.
In type 2 DM, inhibition of -glucosidase therapy is beneficial to delay absorption of glucose after a meal . -glucosidase plays a role in the conversion of carbohydrates into glucose. By inhibiting -glucosidase, glucose levels in the blood can be returned within normal limits .
Natural resources provide a huge and highly diversified chemical bank from which we can explore for potential therapeutic agents by bioactivity-targeted screenings . As a megabiodiversity country, Indonesia still has a lot of potential unexploited forests to be developed as a source phytopharmaca or modern medicine . Opportunity exploration of medicinal plants is still very wide open in line with the development of herbal industry, herbal medicine, and phytopharmaca. Therefore, researchers try to explore the potential antidiabetic agents with the mechanism of action of -glucosidase inhibition in several plant species from four families: Apocynaceae, Clusiaceae, Euphorbiaceae, and Rubiaceae. The four families were chosen because members of some species have been scientifically proven to have antidiabetic activity. Based on the theory of kinship through a systematic approach to plant (chemotaxonomy), plants with the same family generally have similar chemical content, so it may just have the same potential for the treatment of a disease .
2. Method and Material
2.1. Plant Material
The stem bark and leaves of plants material were collected in November 2010 and identified by Center for Plant Conservation-Bogor Botanical Garden.
Each dried powdered of wood bark, twig and leaves (20 g) were extracted by reflux with ethanol 80% then evaporated.
2.3. Inhibition Assay for -Glucosidase Activity
The inhibition of -glucosidase activity was determined using the modified published method . One mg of -glucosidase (Saccharomyces cerevisiae, Sigma-Aldrich, USA) was dissolved in 100 mL of phosphate buffer (pH 6.8) containing 200 mg of bovine serum albumin (Merck, German). The reaction mixture consisting 10 μL of sample at varying concentrations (0.52 to 33 μg/mL) was premixed with 490 μL phosphate buffer pH 6.8 and 250 μL of 5 mM -nitrophenyl -D-glucopyranoside (Sigma-Aldrich, Switzerland). After preincubating at 37°C for 5 min, 250 μL -glucosidase (0.15 unit/mL) was added and incubated at 37°C for 15 min. The reaction was terminated by the addition of 2000 μL Na2CO3 200 mM. -glucosidase activity was determined spectrophotometrically at 400 nm on spectrophotometer UV-Vis (Shimadzu 265, Jepang) by measuring the quantity of -nitrophenol released from p-NPG. Acarbose was used as positive control of -glucosidase inhibitor. The concentration of the extract required to inhibit 50% of -glucosidase activity under the assay conditions was defined as the IC50 value.
2.4. Kinetics of Inhibition against -Glucosidase
Inhibition modes of sample that had the best -glucosidase inhibiting activity in Clusiaceae, Euphorbiaceae, and Rubiaceae were measured with increasing concentration of -nitrophenyl -D-glucopyranoside as a substrate in the absence or presence of ethanolic extract at different concentrations. Inhibition type was determined by the Lineweaver-Burk plots analysis of the data, which were calculated from the result according to the Michaelis-Menten kinetics.
2.5. Phytochemistry Test
In this research we performed phytochemistry test which consists of alkaloid test with Mayer, Dragendorff, and Bouchardat reagents; Flavonoid test with Shinoda and Wilson Töubock reaction; tannin test with gelatin test, gelatin-salt test, and test with ferrous (III) chloride; glycoside test with Molisch reaction; saponin test with honeycomb froth test; anthraquinone test with Bornträger reaction; terpenoid test with Liebermann-Burchard reagent.
3. Results and Discussion
3.1. Phytochemistry Test
Compounds with -glucosidase inhibitory activity were preliminary identificated by the existence of alkaloid, terpene, saponin, tannin, glycoside, flavonoid, and quinone (Table 1).
3.2. Assay for -Glucosidase Inhibitory Activity
The -glucosidase of S. cerevisiae is used to investigate the inhibitory activity of the rude extracts. -glucosidase inhibitory activity of rude extracts compounds against -glucosidases were determined using -nitrophenyl--D-glucopyranoside (p-NPG) as a substrate and these were compared with acarbose (Table 2). The IC50 values of compounds range from 2.33 μg/mL to 706.81 μg/mL. There are thirty-seven of samples which have IC50 lower than acarbose. Extracts derived from leaves of Garcinia daedalanthera showed inhibitory activity against -glucosidase enzyme significantly, with IC50 value of 2.33 μg/mL. Inhibitory activity of the enzyme -glucosidase at forty-five extracts may be due to the glycoside content in each extract. Glycosides consist of sugars that may be structurally similar to carbohydrate which is a substrate of the enzyme -glucosidase . IC50 value of samples of plant extracts are lower than acarbose because their active chemical compounds have no further fractionation and may have a synergistic effect in inhibiting -glucosidase .
Inhibition mode of leaves extract of Antidesma celebicum from Euphorbiaceae was investigated. Inhibition mode of 80% ethanol extract showed competitive inhibitory mode. This mode may have been due because the structure is similar with glucose. This result is similar with inhibition mode of Nojirimycin which has a competitive inhibition against -glucosidase  (Figure 1).
Inhibition mode of 80% ethanol extract from Amaracarpus pubescens Blume. leaves had a combination of competitive and uncompetitive inhibition. Combination of competitive and noncompetitive may have been due to the extract having more than one compound that has -glucosidase inhibitory activity  (Figure 3).
In vitro assays of -glucosidase activity showed thirty-seven of forty-five samples had IC50 values of between 2.33 μg/mL and 112.02 μg/mL, which were lower than that of acarbose (117.20 μg/mL). Based on family, 80% ethanol extract from Garcinia daedalanthera Pierre. leaves (Clusiaceae), Antidesma celebicum leaves (Euphorbiaceae), Amaracarpus pubescens Blume. leaves (Rubiaceae), and Willughbeia tenuiflora Dyer ex Hook.f leaves (Apocynaceae) had the highest -glucosidase inhibiting activity with IC50 of 2.33 μg/mL, 2.34 μg/mL, 3.64 μg/mL, and 8,16 μg/mL. Meanwhile, types of enzyme inhibition mechanism from Garcinia kydia Roxb. leaves (Clusiaceae), Antidesma celebicum leaves (Euphorbiaceae), and Amaracarpus pubescens Blume. leaves (Rubiaceae) were noncompetitive inhibitor, competitive inhibitor, and mixed inhibitor. Currently attempts to purify the active compound from leaves extract of Garcinia kydia Roxb. (Clusiaceae), Antidesma celebicum (Euphorbiaceae), and Amaracarpus pubescens Blume. (Rubiaceae) are conducted to understand the inhibitory mechanisms more clearly. Moreover, further in vivo study is also required.
The authors would like thank to Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Indonesia for supporting this project.
- I. Funke and M. F. Melzig, “Traditionally used plants in diabetes therapy—phytotherapeutics as inhibitors of α-amylase activity,” Revista Brasileira de Farmacognosia Brazilian Journal of Pharmacognosy, vol. 16, no. 1, pp. 1–5, 2006.
- S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004.
- Department of Health Republic of Indonesia, Pharmaceutical Care for Diabetes Mellitus, Department of Health Republic of Indonesia, Kurihara, Indonesia, 2008.
- K. Y. Kim, K. A. Nam, H. Kurihara, and S. M. Kim, “Potent α-glucosidase inhibitors purified from the red alga Grateloupia elliptica,” Phytochemistry, vol. 69, no. 16, pp. 2820–2825, 2008.
- L. H. Bösenberg and D. G. Van Zyl, “The mechanism of action of oral antidiabetic drugs: a review of recent literature,” Journal of Endocrinology, Metabolism and Diabetes of South Africa, vol. 13, no. 3, pp. 80–88, 2008.
- S. H. Lam, J. M. Chen, C. J. Kang, C. H. Chen, and S. S. Lee, “α-Glucosidase inhibitors from the seeds of Syagrus romanzoffiana,” Phytochemistry, vol. 69, no. 5, pp. 1173–1178, 2008.
- M. S. H. Wahyuningsih, S. Wahyuono, D. Santosa, et al., “Plants exploration from central kalimantan forest as a source of bioactive compounds,” Biodiversitas, vol. 9, pp. 169–172, 2008.
- L. S. De Padua, N. Bunyapiaphatsara, and R. H. M. J. Lemmens, Plant Resources of South-East Asia: Medicinal and Poisonous Plants 1, Prosea Foundation, Bogor, Indonesia, 1999.
- R. T. Dewi, Y. M. Iskandar, M. Hanafi et al., “Inhibitory effect of Koji Aspergillus terreus on α-glucosidase activity and postprandial hyperglycemia,” Pakistan Journal of Biological Sciences, vol. 10, no. 18, pp. 3131–3135, 2007.
- S. Sugiwati, S. Setiasi, and E. Afifah, “Antihyperglycemic activity of the mahkota dewa [Phaleria macrocarpa (scheff.) boerl.] leaf extracts as an alpha-glucosidase inhibitor,” Makara Kesehatan, vol. 13, no. 2, pp. 74–78, 2009.
- A. Andrade-Cetto, J. Becerra-Jiménez, and R. Cárdenas-Vázquez, “Alfa-glucosidase-inhibiting activity of some Mexican plants used in the treatment of type 2 diabetes,” Journal of Ethnopharmacology, vol. 116, no. 1, pp. 27–32, 2008.
- D. S. Lee and S. H. Lee, “Genistein, a soy isoflavone, is a potent α-glucosidase inhibitor,” FEBS Letters, vol. 501, no. 1–3, pp. 84–86, 2001.
- K. B. Storey, Functional Metabolism: Regulation and Adaptation, Wiley-Interscience, Hoboken, NJ, USA, 2004.